Nardo Christopher J. 4
4 · Dermata Therapeutics, Inc. · Filed Jul 7, 2022
Insider Transaction Report
Form 4
Nardo Christopher J.
Senior VP, CDO
Transactions
- Award
Stock Option (right to buy)
2022-07-01+30,000→ 30,000 totalExercise: $0.51Exp: 2032-06-30→ Common Stock (30,000 underlying)
Footnotes (1)
- [F1]The option will vest as to 25% upon the 12 month anniversary of the grant date, and will vest as to 75% in 36 equal monthly installments commencing on the 12 month anniversary of the grant date.